Immunotherapy plays a vital role in the management of patients with advanced-stage melanoma, and more recently, adoptive cell therapies and cancer vaccines have shown to be viable, novel treatment approaches able to induce complete and durable remissions in patients with melanoma.

In this exclusive podcast, VJOncology speaks to Allison Betof Warner, MD, PhD, from Memorial Sloan Kettering Cancer Center, New York, NY, who discusses the clinical potential of cellular therapies in the management of patients with melanoma, including the use of tumor-infiltrating lymphocyte (TIL) therapies as well as cancer vaccines and the next steps for these novel therapeutic approaches.